Nomura/Instinet Reiterates Neutral Rating on Sun Pharmaceutical Industries Ltd. (SUNP:IN)

May 23, 2024 12:49 AM EDT Send to a Friend
Nomura/Instinet analyst Saion Mukherjee reiterated a Neutral rating and INR1,444.00 price target on Sun Pharmaceutical Industries Ltd. (SUNP:IN).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login